Search research articles
Contact Us
Filters
Showing results (111-120 of 217) with videos related to
Page
of 22
Sort By:
The American Journal of Surgical Pathology
|
January 21, 2015
Clinicopathologic and prognostic significance of multiple hormone expression in pancreatic neuroendocrine tumors
Joo Young Kim, Min-Sun Kim, Ki-Suk Kim, et al.
Clinical Colorectal Cancer
|
February 23, 2017
HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAF
Jae Ho Jeong, Jihun Kim, Yong Sang Hong, et al.
Cancer Research and Treatment
|
May 27, 2017
Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis
Jwa Hoon Kim, Sook Ryun Park, Min-Hee Ryu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2017
Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer
Ji Hyeon Joo, Jin-Hong Park, Jin Cheon Kim, et al.
Cancer
|
February 11, 2004
Clinicopathologic review of 58 patients with biliary papillomatosis
Sang Soo Lee, Myung-Hwan Kim, Sung Koo Lee, et al.
Anticancer Research
|
January 25, 2023
Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer
Chung Ryul Oh, Hyung-Don Kim, Yeon-Mi Ryu, et al.
Cells
|
October 23, 2021
siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model
Jae Yun Jung, Hyun Jin Ryu, Seung-Hwan Lee, et al.
JAMA Oncology
|
March 23, 2023
Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer: The Phase 2b NIFTY Randomized Clinical Trial
Jaewon Hyung, Ilhwan Kim, Kyu-Pyo Kim, et al.
Investigational New Drugs
|
June 28, 2011
Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status
Myoung Joo Kang, Yong Sang Hong, Kyu-pyo Kim, et al.
The American Journal of the Medical Sciences
|
September 21, 2013
The MEK1/2 inhibitor AS703026 circumvents resistance to the BRAF inhibitor PLX4032 in human malignant melanoma cells
Seong Joon Park, Seung-Woo Hong, Jai-Hee Moon, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 217) with videos related to
Sort By:
Page
of 22
The American Journal of Surgical Pathology
|
January 21, 2015
Clinicopathologic and prognostic significance of multiple hormone expression in pancreatic neuroendocrine tumors
Joo Young Kim, Min-Sun Kim, Ki-Suk Kim, et al.
Clinical Colorectal Cancer
|
February 23, 2017
HER2 Amplification and Cetuximab Efficacy in Patients With Metastatic Colorectal Cancer Harboring Wild-type RAS and BRAF
Jae Ho Jeong, Jihun Kim, Yong Sang Hong, et al.
Cancer Research and Treatment
|
May 27, 2017
Phase II Study of Induction Chemotherapy with Docetaxel, Capecitabine, and Cisplatin Plus Bevacizumab for Initially Unresectable Gastric Cancer with Invasion of Adjacent Organs or Paraaortic Lymph Node Metastasis
Jwa Hoon Kim, Sook Ryun Park, Min-Hee Ryu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 25, 2017
Local Control Outcomes Using Stereotactic Body Radiation Therapy for Liver Metastases From Colorectal Cancer
Ji Hyeon Joo, Jin-Hong Park, Jin Cheon Kim, et al.
Cancer
|
February 11, 2004
Clinicopathologic review of 58 patients with biliary papillomatosis
Sang Soo Lee, Myung-Hwan Kim, Sung Koo Lee, et al.
Anticancer Research
|
January 25, 2023
Epithelial-Mesenchymal Transition Phenotype and Peritumoral Immune Cell Infiltration in Advanced Biliary Tract Cancer
Chung Ryul Oh, Hyung-Don Kim, Yeon-Mi Ryu, et al.
Cells
|
October 23, 2021
siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model
Jae Yun Jung, Hyun Jin Ryu, Seung-Hwan Lee, et al.
JAMA Oncology
|
March 23, 2023
Treatment With Liposomal Irinotecan Plus Fluorouracil and Leucovorin for Patients With Previously Treated Metastatic Biliary Tract Cancer: The Phase 2b NIFTY Randomized Clinical Trial
Jaewon Hyung, Ilhwan Kim, Kyu-Pyo Kim, et al.
Investigational New Drugs
|
June 28, 2011
Biweekly cetuximab plus irinotecan as second-line chemotherapy for patients with irinotecan-refractory and KRAS wild-type metastatic colorectal cancer according to epidermal growth factor receptor expression status
Myoung Joo Kang, Yong Sang Hong, Kyu-pyo Kim, et al.
The American Journal of the Medical Sciences
|
September 21, 2013
The MEK1/2 inhibitor AS703026 circumvents resistance to the BRAF inhibitor PLX4032 in human malignant melanoma cells
Seong Joon Park, Seung-Woo Hong, Jai-Hee Moon, et al.
Page
of 22